But the company, a US arm of German drug maker Merck KGaA, has 19 other cancer drug research programs in different stages of development, said Luciano Rossetti, Merck’s global head of research and development.
Advertisement Bavencio will be EMD Serono’s first cancer drug launch.
Federal regulators Thursday approved a drug to treat Merkel cell carcinoma, a rare and aggressive form of skin cancer, boosting efforts by Rockland-based biotech EMD Serono to expand its franchise in treatments that target specific types of cancer molecules.
Sign up for more newsletters hereRossetti said he was celebrating the Bavencio approval Thursday afternoon by drinking champagne with scientists in Billerica who had worked on the program.
The drug, called Bavencio, was approved for patients at least 12 years old, including those who have not yet received chemotherapy.
FDA: Breast implants linked to 9 deaths from rare cancer anaplastic large cell lymphoma (ALCL)
ALCL is not a form of breast cancer, but it grows in the breast in implant patients.
Just like with breast cancer, if you find a mass in your breast, go get it checked out,” DiNome said.
Nine deaths from a rare form of cancer have been linked to breast implants, the Food and Drug Administration announced Tuesday.
Doctors and patients can go to The Plastic Surgery Foundation’s website to report cases of anaplastic large cell lymphoma thought to be linked to breast implants.
But the current data suggests the rare form of cancer occurs more frequently with textured-surface breast implants versus those with smooth surfaces.
This content may collect you by Sydney Connor